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Summary
Vertebrate limb regeneration occurs in anamniotes
such as newts, salamanders, and zebrafish [1–4]. After
appendage amputation, the resection site is covered by
a wound epidermis capping the underlying mature tis-
sues of the stump from which the blastema emerges.
The blastema is a mass of progenitor cells that consti-
tute an apical growth zone. During outgrowth forma-
tion, the proximal blastemal cells progressively leave
the zone and undergo the differentiation that results in
the replacement of the amputated structures. Little is
known about the mechanisms triggering regenerative
events after injury. The zebrafish caudal fin provides
a valuablemodel to study themechanismsof regenera-
tion [3, 5, 6]. Zebrafish blastemal cells express specific
genes, such as the homeobox-containing transcription
factorsmsxBandmsxC [7], andsecretedsignalFGF20a
[8]. In this study, we set out to identify signals that are
transcriptionally upregulated after fin amputation and
before blastema formation. Accordingly, a gene encod-
ingaTGFb-related ligand,activin-bA (actbA),was found
tobestrongly inducedwithin 6hr after finamputationat
the wound margin, and later in the blastema. Inhibition
of Activin signaling through two specific chemical
inhibitors, SB431542 and SB505124, lead to the early
and complete block of regeneration. The morpholino
knockdown of actbA and its receptor alk4 impaired
the progression of regeneration. Closer examination
of the phenotype revealed that Activin signaling is nec-
essary for cell migration during wound healing and
blastemal proliferation. These findings reveal a role of
Activin-bA signaling in the tissue repair after injury
andsubsequentoutgrowth formationduringepigenetic
regeneration of the vertebrate appendage.
Results and Discussion
actbA Is Transcriptionally Upregulated
during Fin Regeneration
To identify early signals triggering regeneration, we per-
formed Affymetrix microarray analyses comparing con-
trol fins collected immediately after amputation with
regenerating fins at 6 hr postamputation (6 hpa) and at
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bridge, Massachusetts 02139.28.5C. This time point falls into the phase during wound
healing and before blastema formation. The transcrip-
tome analysis lead to the identification of activin-bA
in regenerating fins (inhibin-bA, actbA; Table S1 in the
Supplemental Data available online). Act-bA is a se-
creted ligand that signals through a serine-threonine ki-
nase complex consisting of type I receptor ActBIB (Alk4)
and type II receptor ActRIIA or ActRIIB [9]. In order to
examine the requirement of actbA, we intended to
suppress the activity of its Alk4 receptor. Quantitative
reverse transcription-polymerase chain reaction (RT-
PCR) and in situ hybridization verified that the alk4
receptor is expressed in regenerating fins (Figures S1A
and S1C). Given that the Alk4 receptor mediates the sig-
naling of several structurally related ligands, we deter-
mined the expression of activin-bA, activin-bB, TGFb1,
TGFb2, TGFb3, GDF8, GDF11, and the three nodal-re-
lated genes squint, cyclops, and southpaw [10]. Among
ligands that are expressed in fins, activin-bA was the
only gene transcriptionally upregulated during fin regen-
eration (Figures S1A and S1B). In comparison with 0 hpa
fin samples, a nearly 5-fold increase of actbA transcript
levels was detected as early as 1 hpa (Figure 1B). The
highest upregulation of 18-fold was identified at 6 hpa,
and it slightly declined at 24 hpa (Figure 1B).
The fin is composed of rays that are supported by der-
mal bones called lepidotrichia or hemirays [3, 5]. Rays
are connected to each other through soft tissue inter-
rays that lack skeletal elements. To visualize the expres-
sion of actbA in fins, we performed in situ hybridization.
The first signal was detected at 6 to 12 hpa in mesenchy-
mal cells at the wound margin of the interrays (Figures
1A and 1C). At 24 hpa, actbA transcription was also in-
duced at the epidermal-mesenchymal boundary in the
ray region where the blastema forms (Figure 1E). During
regenerative outgrowth phase at 72 hpa, the expression
of actbAwas maintained in the blastema and declined in
the initial interray domains (Figure 1G). We hypothesized
that the early actbA expression in the interray pockets
comprised a mesenchymal zone that is distinct from
the blastema. To test this idea, we analyzed actbA ex-
pression in the amputated fins bearing the devoid of
blastema (dob) mutation, a temperature-sensitive allele
of the FGF20a gene [8]. In dob mutant fins, at 24 and
72 hpa at the restrictive temperature of 33C, actbA
expression was not detected in the ray mesenchyme,
consistent with the notion that FGF20a is required for
blastema formation (Figures 1F and 1H). However, the
interray domains of actbA expression were normally es-
tablished at 6 hpa and maintained at later stages at 24
and 72 hpa (Figures 1D, 1F, and 1H). This demonstrates
that the early actbA expression domain is independent
of blastema formation.
Inhibition of Activin-bA Signaling Blocks
Regeneration
To test whether actbA is required during regeneration,
we applied a pharmacological strategy to block
ActbA Is Required for Fin Regeneration
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molecules, 10 mM SB431542 and 2 mM SB505124, that
specifically block Alk4/5/7 receptor, not affecting other
Alk family members, as well as other signal transduction
pathways [11, 12]. SB431542 (Alk4-i) was shown to in-
hibit the Activin type I receptor in zebrafish embryos
[13, 14]. SB505124 caused the same embryonic defects
as did Alk4-i, and so did the overexpression of a domi-
nant-negative Alk4 receptor (Figure S2). The similarity
of embryonic phenotypes in pharmacological and
Figure 1. actbA Is Expressed in an Interray Domain and in the
Blastema
(A and C–H) In situ hybridization of fins with actbA mRNA antisense
probe (blue staining). Scale bars in (A) represent 100 mm.
(B) Real-time RT-PCR quantification of actbA expression in fins at 1,
3, 6, and 24 hpa (n = 4) relative to control fins at 0 hpa (n = 3), which as
a calibrator sample were normalized to 1.00. Error bars represent the
standar error of the mean (SEM). p < 0.001 indicates a significant
difference from the control. n refers to the number of biological sam-
ples; each sample was prepared from 15–20 fins.
(A, C, E, and G) Wild-type fins at different stages of regeneration.
Each panel shows a longitudinal section (left) and a fragment of
the whole-mount fin (right). At 6 hpa, actbA is detected in scattered
mesenchymal cells along the wound epidermis of the interrays (A).
The ray contains dermal bones; the interray spans soft tissue be-
tween rays. At 12 hpa, the expression expands in the mesenchyme
of the interray pockets at the cut edge (C). At 24 hpa, actbA is
additionally induced in the mesenchyme underlying the wound
epidermis of the rays, where the blastema is formed (arrows) (E).
At 72 hpa, the expression is strongly detected in the blastema
(arrows) (G).
(D, F, and H) actbA expression is independent of FGF20a signaling.
dob homozygous mutant fins were incubated at a restrictive tem-
perature of 33C. actbA mRNA is expressed in the interray pockets
of dob mutant fins at 6 hpa (D), 24 hpa (F), and 72 hpa (H). No or
little activin A expression is detected in the ray mesenchyme (ar-
rows) because the blastema fails to form in dob mutants (n = 6).genetic assays confirms the specificity of both small
molecules in zebrafish.
The examination of amputated fins treated with Alk4-i
revealed normal re-epithelialization of the wound at 3 hpa:
Several layers of epithelial cells covered the resection site
(Figures 2A–2D). The initial healing was associated with
the deformation of the wound margin that acquired a ser-
rate-like appearance because of the retraction of the in-
terrays from the amputation plane (Figures 2C and 2D).
We anticipated that the receding of the fin interrays is
caused by the mechanical tension within the tissue
that pulls away the tissue edges from the cut. In contrast
to the soft interrays, the skeletal elements of the rays
supported the tissue and prevented from retraction.
Examination of control fins at 6 to 12 hpa revealed the
restoration of the fin margin (Figure 2E). However, the
stump repair did not occur in fins treated with Alk4-i
(Figure 2F). As a result, the truncated fins developed a
serrate phenotype (Figure 2H). Similar phenotype was
observed after SB505124 treatment (data not shown).
The invaginations of the interrays correlate with the
early expression domains of actbA (Figures 1A and
1C). This suggests the role of actbA during stump re-
pair. What cellular defects might account for the early
block of regeneration at the phase of stump repair?
As shown by BrdU-cell-proliferation assay (Figure S3),
and consistent with previous studies [15, 16], enhanced
cell-cycle entry was not observed between 1 and 12
hpa. It has been suggested that cell migration is essen-
tial for the initial repair of the damaged tissue before
blastema formation [3, 5]. We used the phosphorylated
c-Jun (p-Jun) marker [17] to visualize the migrating
epidermal edge at 6 and 12 hpa. Alk-i treatment dimin-
ished the p-Jun domain by approximately 75% com-
pared to untreated cut fins (Figure S3). The results sug-
gest that the Activin-dependent restoration of the
deformed wound margin involves the activation of the
c-Jun pathway.
To understand the complete lack of regeneration in
fins treated with the Alk4-i, we assessed cellular mech-
anisms that normally contribute to blastema formation:
the reorganization and proliferation of the ray mesen-
chyme at 18 to 24 hpa [3]. We found that the antibody
against tenascin abundantly labeled disorganized mes-
enchyme proximal to the amputation plane (Figure 3A
and Figure S3H). Tenascin is a large extracellular matrix
protein that has been shown to be induced during tissue
remodeling in mammalian wound healing and limb re-
generation in newts [18, 19]. Inhibition of ActbA signaling
resulted in a 2-fold reduction of the tenascin expression
domain in the mesenchyme when compared with con-
trol fins (Figures 3A and 3B). These data suggest a mes-
enchymal remodeling defect in fins with blocked ActbA
signaling.
To address the mitogenic role of ActbA, a BrdU-label-
ing assay was performed. Cell proliferation, which is
normally enhanced in disorganized mesenchyme at 24
hpa [16], was reduced by approximately 75% after
Alk4-i treatment as compared to control (Figures 3A
and 3B, Figure S4E). Epidermal proliferation, on the
other hand, was enhanced by the Alk4-i incubation.
We concluded that the mitogenic role of ActbA signaling
is tissue dependent: it has a stimulating effect on mes-
enchyme that gives rise to the blastema but not on the
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generative outgrowth in fins with blocked ActbA signal-
ing is caused by impaired mesenchymal disorganization
and proliferation.
To determine the effect of Alk4-i on molecular specifi-
cation of the blastema, we performed in situ hybridi-
zation with a msxB probe. At 48 hpa, msxB marks
a mass of blastema cells distal to the amputation plane
[7] (Figure 3C). In the amputated fins treated with Alk4-i,
msxB was induced only in a single row of mesenchymal
cells just beneath the wound epidermis (Figure 3D). No
expression of msxB was apparent at 4 days postampu-
tation (dpa) or later (data not shown). Thus, rudimentary
blastema cells are specified in fins with blocked ActbA
signaling, even though they fail to expand distally from
the amputation plane.
Figure 2. Inhibition of ActbA Signaling Blocks Zebrafish Fin Regen-
eration with the Serrate Phenotype
(A and B) Fins shortly after amputation. n = 4. The scale bar in (A) rep-
resents 200 mm.
(C and D) After 3 hpa, the epidermis covered the wound. The inter-
rays acquired indentations along the amputation plane, as indicated
by arrows in both control (C) and Alk4-i-treated fins (D).
(E and F) At 6 hpa, the interray gap closure occurs in control fins (E)
but is suppressed in the presence of the inhibitor (arrows in [F]).
(G and H) After 10 dpa, the control fins completed regeneration (G),
whereas the fins treated with the inhibitor did not regenerate and
displayed the serrate phenotype, as seen in the inset (H). The red
line in (G) marks the amputation plane.Activin Signaling Is Essential to Maintain Blastema
Progenitor Cells
To determine the requirement of ActbA signaling for the
function of the normally established blastema, we per-
formed a drug-shift experiment. Fins were first allowed
to form an outgrowth for 3 days in normal conditions,
and then they were exposed to Alk4-i for 6, 12, or 24
hr. The control and experimental fish were kept in the
presence of BrdU for the last 6 hr of the experiment,
and cell proliferation was assessed. In all control sam-
ples, BrdU labeled most of the cells within the blastema
located in the distal part of the outgrowth (Figure 3E and
data not shown). Cell proliferation was not altered by
6 hr of Alk4-i incubation; however, after 12 hr of drug
exposure, blastemal proliferation was approximately
50% reduced, and further reduction was observed after
24 hr of drug shift (Figures 3E and 3F, Figures S4A, S4B,
and S4F). The expression of msxB was diminished after
24 hr of drug incubation (Figure 3G and 3H). This rapid
decrease of BrdU incorporation suggests that the pro-
genitor cells of the regenerate either underwent apopto-
sis or exited the cell cycle. The TUNEL assay excluded
the first possibility because it did not reveal increase
of cell death in mesenchyme of the Alk4-i-treated fins
(Figures S4C and S4D and data not shown). We con-
cluded that the ActbA function is required to maintain
the proliferative potential of the blastema.
To further test the role of ActbA signaling during the
outgrowth phase, we used a knockdown morpholino
(MO) technology [20]. Recently, this approach was dem-
onstrated in regenerating fins: MO was delivered into the
soft outgrowth tissue by microinjection, and in vivo elec-
troporation followed [21]. In this study, fluorescein-
tagged alk4, actbA, and control MOs were injected into
either the ventral or dorsal half of fin regenerates at 3
dpa, and electroporation followed. The remaining non-
injected half of the regenerate served as control tissue
(Figure 4). The effect of the MOs was assessed at 2
days after injection (5 dpa) by the comparison of the out-
growth size of the experimental and control fin halves.
Although the control MOs displayed normal outgrowth,
the actbA- and alk4-specific MOs resulted in approxi-
mately 50% and 80% reduction of the regenerate,
respectively (Figure 4). Microscopic analysis of fin sec-
tions at 2 days after alk4-MO delivery revealed a rela-
tively large number of mesenchymal and epidermal cells
in the distal outgrowth that retained fluorescein-tagged
MOs (Figure 4H). We concluded that MO-mediated
knockdown of alk4 and actbA during the fin-outgrowth
phase impairs normally initiated regeneration.
We demonstrated that actbA is transcriptionally in-
duced during wound healing. Wound re-epithelialization
is accompanied by the retraction of the soft interray tis-
sue with respect to the rigid rays leading to the formation
of edge indentations (Figures S5A and S5B). The fin is
able to realign the retracted wound margin within a short
time of 6 to 12 hpa (Figure S5C). We identified that this
early regenerative event requires Activin signaling be-
cause its block leads to the serrate phenotype. The
saw-toothed phenotype of the amputated edge has
also been observed after the blocking of fibroblast
growth factor (FGF) signaling with a small-molecular-
weight inhibitor [22]. Further studies will be needed to
address a possible relation between both phenotypes.
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Maintenance
(A and B) Longitudinal sections of the fin rays at 24 hpa, triply stained
with BrdU antibody in green, anti-tenascin in red, and ToPro3 in
blue. In the control, the enhanced number of BrdU-positive cells in
the epidermis and mesenchyme indicates a proliferative phase of re-
generation (A). The mesenchymal domain with proliferating cells
overlaps with the tenascin domain. Fins treated with 10 mM Alk4-i
contain an enhanced number of BrdU-positive cells in the epidermis,
but mesenchymal proliferation is decreased (B). The extent of tenas-
cin domain is reduced to half size when compared to control (two to
three representative sections of four fins were analyzed). The scale
bar in (A) represents 100 mm.
(C and D) In situ hybridization of fins with msxB antisense probe. At
48 hpa, control fins display strong msxB expression distally from the
amputation plane in the blastema, as seen on a whole mount (left
panel) and a longitudinal section (right panel) (C). Inhibition of ActbA
completely depletes msxB (35% of the rays in five fins) or reduces
msxB expression to a single row of mesenchymal cells that remain
at the amputation plane (65% of the rays in five fins) (D).
(E and F) Longitudinal sections of the fin rays at 4 dpa (3 days at nor-
mal conditions and 24 hr with 0.1% DMSO) triply stained with BrdU
antibody in green, anti-pan-keratin in red, and DAPI in blue. The
white lines demarcate the amputation plane. In control fins, the blas-
tema (arrowheads) displays a massive proliferation, as visualized byThe early actbA domain is distinct in three ways from the
blastema. First, the interray actbA expression domain is
not altered in FGF20a mutant dob, which lacks the blas-
tema [8]. Second, this actbA domain does not display
enhanced proliferation, which is one of the most con-
spicuous markers for the developing blastema. Third,
the classical blastemal markers such as msxB and
msxC are not expressed in the interray pockets during
wound healing [7, 16]. Thus, actbA expression demar-
cates a previously uncharacterized mesenchymal zone
that might be involved in stump repair.
The creation of progenitor blastema cells is the key
event during epimorphic limb regeneration [3]. We dem-
onstrated that actbA is expressed in the blastema
(Figure S5D). ActbA signaling is required for the subse-
quent growth and maintenance of the blastema. The
process of cell proliferation during fin regeneration has
been shown to be controlled by FGF signaling [8, 23]. Al-
though FGF signaling impacts the proliferation of both
epidermal and mesenchymal cells, the inhibition of
ActbA blocks only blastemal proliferation. Thus, ActbA
represents a specific blastemal mitogenic factor during
zebrafish fin regeneration.
Experimental Procedures
Animal Procedures
The following zebrafish strains were used in this study: wild-type
EKKWill (Waterlife Resources [Gibsonton, FL]), a wild-type AB strain
(Oregon) and a devoid of blastema (dob) temperature-sensitive mu-
tant [8]. Fish 6–24 months of age were anaesthetized in 0.1% tricane,
and caudal-fin amputations were performed with razor blades. Ani-
mals were allowed to regenerate for various times at 28.5C, except
for dob, which was at a restrictive temperature of 33C. Alk4/5/7 in-
hibitors SB431542 (Tocris) and SB505124 (Sigma-Aldrich) were dis-
solved in dimethyl sulfoxide (DMSO) at 10 mM stock concentration
and added to fish water at a final concentration of 10 mM and 2
mM, respectively. The control animals were in water with 0.1%
DMSO. Up to eight fish were treated in 1 l of water at 28.5C that
was changed daily. For proliferation assays, BrdU (Sigma-Aldrich)
was dissolved in fish water at a concentration of 50 mg/ml, and the
incubation time was 6 hr. Fish survived and demonstrated no un-
usual behavior while in the presence of SB431542, SB505124, or
BrdU solution.
Morpholino Knockdown
All morpholinos (MOs) used in this study were tagged with fluores-
cein (Gene Tools [www.gene-tools.com]) and resuspended in the
13 Danieau buffer [21] at 1.5 mM concentration for injection. The
MO sequences were as follows: against alk4 50-CTGCAACATTCC
CATCTCTTAGCAT-30, against actbA 50-GGACATCCTTAAATAAAA
GGTGTCT-30, and control actbA 5 mispaired 50-GGAGATCGTTAATT
AAAACGTCTCT-30.
BrdU incorporation, and no keratin staining (E). The intensity of ker-
atin is correlated with mesenchymal differentiation: high levels in the
proximal mesenchyme (above the amputation plane) and no staining
in the blastema. Keratin staining strongly labels the epidermis. Fins
regenerating in normal conditions for 3 days and then transferred to
water with Alk4-i for the next 24 hr (drug-shift experiment) are shown
(F). The smaller size of the outgrowth and reduction of blastemal
proliferation demonstrates a block of normally initiated regeneration
after the exposure to the drug. Two to three representative sections
of four fins were analyzed.
(G and H) In situ hybridization of fins with msxB antisense probe. In
control fins at 4 dpa (3 days at normal conditions and 24 hr with 0.1%
DMSO), msxB mRNA is detected in the blastema of the outgrowth
(G). msxB expression is strongly diminished in fins exposed to
Alk4-i for 24 hr starting at 3 dpa (four out of six fins). (H)
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formed as previously described [21] with minor modifications. MOs
were injected into one half (either dorsal or ventral) of the regenerate
at 3 dpa. The other noninjected half of the fin was considered as the
internal control to monitor normal growth. After injection, the entire
fin was electroporated with a 5-mm-diameter tweezer electrode and
Electro Square Porator ECM 830 (BTX, Harvard Apparatus) applying
the following parameters: five pulses of 15V and of 50 ms duration
Figure 4. Morpholino-Mediated actA and alk4 Knockdowns Impair
Fin Regeneration
(A–F) Fins microinjected on one side with control (A and B), actA (C
and D), and alk4 (E and F) fluorescein-tagged MOs and then electro-
porated. Bright-field and fluorescent images show fins at 3 dpa
shortly after MO delivery to the regenerate (A, C, and E). Fluorescent
MOs (green) are seen only in the injected half of the fin. The remain-
ing noninjected half of the fin served an internal control for the
growth rate. Corresponding images of the fins 2 days after MO de-
livery (5 dpa) are shown (B, D, and F). The control MO does not affect
the size of the outgrowth relative to the noninjected side of the fin (B).
The actbA and alk4 MOs impair the growth of the injected fin relative
to the noninjected side, leading to the asymmetric shape of the re-
generate (D and F).
(G) Graph comparing the length of regenerates that regrew within
2 days after MO delivery in relation to the nontreated fin regenerate.
It depicts the percent length of the outgrowth of the experimental
side in relation to the control side (ten fins were analyzed, five
of which were either ventrally or dorsally injected). Error bars rep-
resent the SEM. The asterisks denote the significant difference,
p < 0.005.
(H) Longitudinal section of the fin at 2 days after the alk4 fluorescent
MOs delivery (5 dpa). Fluorescent (green) cells are identified in the
epidermis and within the mesenchymal tissue distal to the amputa-
tion plane, indicating the efficiency of MO incorporation. DAPI in
blue labels all nuclei.with a 30 s pause between pulses. After the procedure, fins were
photographed in bright field and in fluorescence with a GFP2 filter
(Leica MZFLIII microscope with an AxioCam MRc Zeiss camera).
The same fins were photographed again 2 days after morpholino
delivery.
For the measurement of regenerate length, the distance from the
amputation plane of five lateral rays to the tip of the outgrowth was
determined with Abode Photoshop CS2 software. The values ob-
tained for the symmetric rays from the experimental and control
sides (located at the same position with respect to the most lateral
ray) were used to calculate the percent length of the outgrowth ap-
plying the formula: (Exp5 days2 Exp3 days)/(Cont5 days2 Cont3 days)3
100, where Exp is the length of the outgrowth of the MO-treated re-
generate and Cont is the length of the corresponding outgrowth of
the noninjected control side.
In Situ Hybridization
To generate antisense and control sense RNA probes, portions of
the coding sequences of genes were cloned by the PCR amplifica-
tion of zebrafish embryonic cDNA. The forward and reverse primers
were synthesized with an addition of the promoter for T7 or T3 RNA
polymerase, respectively. The following forward (F) and reverse (R)
primers were used: for actbA, F: 50-GGGATCCTCCTGCTGCTAAT-
30 and R: 50-AGTGGAAGGACAGCGAGTTG-30 (991 bp); for actbB,
F: 50-AAGATTCGGGGAGAATGGAC-30 and R: 50-GTTAGGCACGTC
ACGTTTGA-30 (1004 bp); for alk4, F: 50-CAACAGCATCAACCT
CCAGA-30 and R: 50-CGGCACCAGGTCATAGTAGG-30 (1000 bp);
for squint (NM_130966), F: 50-GCACCTCTACCGGACACTTC-30 and
R: 50-TGACCATCTTGCCATTCTCA-30 (953 bp); and for msxB
(NM_131260), F: 50-GAGAATGGGACATGGTCAGG-30 and R: 50-
GCGGTTCCTCAGGATAATAAC-30 (721 bp). Dig-labeled RNA anti-
sense and sense probes were synthesized from PCR products
with the Dig labeling system (Roche). In situ hybridization of
zebrafish fins was performed as described [22] with proteinase K
(20 mg/ml, Sigma-Aldrich) treatment adjusted to the stage of the
regenerate: 1–2 min incubation for fins at 6 hpa and 12 hpa, 5–7
min for fins at 24 hpa, and 10–15 min for fins at 48 hpa or later
time points.
Immunohistochemistry
The following primary antibodies were used: mouse anti-human ker-
atin, pan antibody cocktail at 1:500 (USBiological); rabbit anti-
chicken Tenascin at 1:500 (USBiological); rabbit anti-phospho-c-
Jun (Ser73) at 1:200 (Cell Signaling Technology); and rat anti-BrdU
at 1:200 (Abcam). The following secondary antibodies were used:
donkey anti-mouse Cy3-conjugated at 1:500 (Jackson ImmunoRe-
search); goat anti-rabbit Cy3-conjugated at 1:500 (Jackson Immu-
noResearch); goat anti-rabbit Alexa Fluor 488 at 1:500 (Molecular
Probes); and goat anti-rat Alexa Fluor 488 at 1:500 (Molecular
Probes). ToPro3 (Molecular Probes) was used at a concentration
of 1:500 to label all nuclei.
Fins were fixed in 4% paraformaldehyde, cryosectioned, and im-
munostained as previously described [16]. The images were taken
with confocal microscopy (Nikon). To quantify BrdU- and phos-
pho-c-Jun-positive nuclei, a number of immunostained cells were
normalized to ToPro3-stained nuclei in each section. The inhibitor-
induced change in the number of immunostained cells was calcu-
lated as a percentage of control values.
Supplemental Data
Experimental Procedures, five figures, and one table are available at
http://www.current-biology.com/cgi/content/full/17/16/1390/DC1/.
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